iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: http://pubmed.ncbi.nlm.nih.gov/16163448/
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Feb;76(3):283-91.
doi: 10.1007/s11060-005-7020-9.

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas

Paul D Brown  1 , Karla V Ballman, Teresa A Rummans, Matthew J Maurer, Jeff A Sloan, Bradley F Boeve, Lalit Gupta, David F Tang-Wai, Robert M Arusell, Matthew M Clark, Jan C Buckner
Affiliations
Comparative Study

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas

Paul D Brown et al. J Neurooncol. 2006 Feb.

Abstract

Objective: To assess baseline quality of life (QOL) and its prognostic importance for adults with newly diagnosed high-grade gliomas, we analyzed QOL and outcome data prospectively collected in three phase II high-grade glioma protocols.

Methods: At study entry, patients completed five self-administered forms to assess overall QOL (linear analogue scale assessment [LASA] and Functional Assessment of Cancer Therapy-Brain [FACT-Br]); fatigue (Symptom Distress Scale [SDS]); excessive daytime somnolence (Epworth Sleepiness Scale [ESS]); and depression (POMS-SF). Folstein Mini-Mental State Examination (MMSE) and Eastern Cooperative Oncology Group (ECOG) performance scores (PS) were obtained by the health care provider.

Results: Baseline QOL data were available for 194 of 220 patients (88%) enrolled in the three protocols. Differences in baseline QOL among the three studies were not statistically significant. One-third of patients had clinically significant fatigue at baseline. Increased fatigue (P = 0.003), excessive daytime somnolence (P = 0.01), and lower overall QOL scores (LASA, P = 0.001; FACT-Br, P = 0.0001) correlated with worse ECOG PS. No relation was found between QOL and corticosteroid or anticonvulsant therapy, extent of resection, tumor grade, or sex. Multivariate analyses found worse ECOG PS (PS 2, P = 0.007) associated with increased fatigue. Worse ECOG PS (PS 2, P = 0.002) was also associated with worse overall QOL (LASA). On multivariate analyses of survival, increased fatigue (P = 0.003) predicted poorer overall survival.

Conclusions: Performance status is related to QOL in patients with newly diagnosed high-grade brain tumors. Increased fatigue is an independent predictor of overall survival. Interventional studies directed at improving QOL, especially fatigue, may have important benefits for these patients.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurooncol. 1997 Sep;34(3):263-78 - PubMed
    1. Percept Mot Skills. 1987 Aug;65(1):64-6 - PubMed
    1. Stat Med. 1992 Dec;11(16):2093-109 - PubMed
    1. Cancer. 2001 Jul 15;92(2):420-33 - PubMed
    1. Qual Life Res. 1996 Feb;5(1):139-50 - PubMed

Publication types

LinkOut - more resources